Stefano Ferrari

Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.

J. Mestan, C. Schnell, S. Mandriota, 2001, The Journal of pharmacology and experimental therapeutics.

Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agent.

J. Mestan, D. Fabbro, T. Meyer, 1999, Pharmacology & therapeutics.

New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis

Stover, Roth, J. Mestan, 2000, Journal of medicinal chemistry.